Clinical trials: Patient Population With Multivessel Disease
- Condition Patient Population With Multivessel Disease
- Funder type Industry (pharma, biotech, devices)
Patient Population With Multivessel Disease
CRUZ Tunisia-Multivessel Registry
The primary objective of this registry is to evaluate the safety and clinical performance of the biodegradable polymer-coated Supraflex Cruz Sirolimus-eluting Stent (SES) in an unselected, all-comer patient population with…
- Trial name
- NCT06663696
- Testing
- Supraflex Cruz Sirolimus-eluting Coronary Stent System
- Where
- 2 sites in Tunisia
- Volunteers
- 1,000 people
- Sponsor
- Sahajanand Medical Technologies Limited